Suppr超能文献

5-HT2与5-HT1C皮质受体配体选择性的分子结构基础。

Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.

作者信息

Pierce P A, Kim J Y, Peroutka S J

机构信息

Department of Neurology, Stanford University School of Medicine, CA 94305.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):4-11. doi: 10.1007/BF00167563.

Abstract

A molecular structural criterion of ligand selectivity for the 5-HT2 versus 5-HT1C receptor was hypothesized on the basis of radioligand binding data. Despite the large number of compounds which have been tested at both receptors, analysis of published data led to the identification of only five agents which are greater than 10-fold selective for the 5-HT2 versus the 5-HT1C receptor. Comparison of the two-dimensional structures revealed that, although these five compounds represent three distinct structural classes, they share a common structural feature located in the region hypothesized to be involved in receptor binding: a carbonyl or carboxyl oxygen interposed spatially between an aromatic ring and nitrogen atom. This structural feature was used to predict the relative selectivity of compounds that had not previously been analyzed at both the 5-HT2 and 5-HT1C receptors. All six drugs tested which contain the identified reactive carbonyl or carboxyl group were found to be selective for the 5-HT2 versus the 5-HT1C receptor with selectivity ratios ranging from 26 to 380. By contrast, three agents which are structurally similar but do not contain the reactive carbonyl or carboxyl group displayed equally high affinity for both receptor binding sites. Since the physiological roles of the 5-HT2 and 5-HT1C receptor are markedly different, it would be of potential clinical and scientific value to utilize this molecular structural feature to further identify chemical compounds which would selectively interact with only one of the two receptors.

摘要

基于放射性配体结合数据,推测了5-HT2受体与5-HT1C受体配体选择性的分子结构标准。尽管已有大量化合物在这两种受体上进行了测试,但对已发表数据的分析仅发现了五种对5-HT2受体与5-HT1C受体的选择性大于10倍的药物。二维结构比较显示,虽然这五种化合物代表了三种不同的结构类别,但它们在假定参与受体结合的区域共享一个共同的结构特征:一个羰基或羧基氧在空间上介于一个芳环和氮原子之间。这一结构特征被用于预测此前未在5-HT2和5-HT1C受体上进行分析的化合物的相对选择性。所测试的六种含有已确定的活性羰基或羧基的药物对5-HT2受体与5-HT1C受体具有选择性,选择性比率在26至380之间。相比之下,三种结构相似但不含有活性羰基或羧基的药物对两个受体结合位点显示出同样高的亲和力。由于5-HT2和5-HT1C受体的生理作用明显不同,利用这一分子结构特征进一步鉴定仅选择性地与这两种受体之一相互作用的化合物,可能具有潜在的临床和科学价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验